TOBIN JAMES R — SEC insider filings
SEC reporting owner CIK 1190128. 38 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers all 38 filings on record, filed 2020-08-26 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 31 legs across 18 filings — 383,218 shares, $24,707,617 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 55.
- Largest priced transaction: sale of 37,662 shares @ $75.10 ($2,828,510) in GLOBUS MEDICAL INC, filed 2026-11-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TransMedics Group, Inc. (TMDX) | Director | 20 | — | 22 legs · 240,218 sh · $14,671,984 | 12 |
| GLOBUS MEDICAL INC (GMED) | Director | 13 | — | 9 legs · 143,000 sh · $10,035,634 | 30 |
| Oxford Immunotec Global PLC (OXFD) | Director | 1 | — | — | 9 |
| Lyra Therapeutics, Inc. (LYRA) | Director | 4 | — | — | 4 |
Insider filings — TOBIN JAMES R
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 4 | TransMedics Group, Inc. (TMDX) | Sale (S): 59 @ $93.96 · Sale (S): 4,000 @ $94.98 | EDGAR |
| 2026-11-12 | 4 | GLOBUS MEDICAL INC (GMED) | Option exercise (M): 15,000 @ $65.05 · Option exercise (M): 21,458 @ $53.27 · Option exercise (M): 5,208 @ $43.58 · Sale (S): 37,662 @ $75.10 · Sale (S): 4,004 @ $75.68 · Option exercise (M): 15,000 (derivative) @ $0 · +2 more | EDGAR |
| 2026-09-16 | 4 | GLOBUS MEDICAL INC (GMED) | Option exercise (M): 15,000 @ $53.75 · Option exercise (M): 15,000 @ $63.68 · Sale (S): 30,000 @ $74.58 · Option exercise (M): 15,000 (derivative) @ $0 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-08-17 | 4 | TransMedics Group, Inc. (TMDX) | Gift (G): 18,000 @ $0 | EDGAR |
| 2026-05-22 | 4 | TransMedics Group, Inc. (TMDX) | Grant/award (A): 2,922 @ $0 | EDGAR |
| 2026-01-23 | 4 | GLOBUS MEDICAL INC (GMED) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | TransMedics Group, Inc. (TMDX) | Grant/award (A): 2,134 @ $0 | EDGAR |
| 2025-05-16 | 4 | Lyra Therapeutics, Inc. (LYRA) | Grant/award (A): 32,000 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | GLOBUS MEDICAL INC (GMED) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-09-17 | 4 | TransMedics Group, Inc. (TMDX) | Gift (G): 18,000 @ $0 · Gift (G): 18,000 @ $0 | EDGAR |
| 2024-08-09 | 4 | TransMedics Group, Inc. (TMDX) | Sale (S): 12,664 @ $158.96 · Sale (S): 7,336 @ $159.96 | EDGAR |
| 2024-06-14 | 4 | Lyra Therapeutics, Inc. (LYRA) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | TransMedics Group, Inc. (TMDX) | Grant/award (A): 732 @ $0 · Grant/award (A): 1,154 (derivative) @ $0 | EDGAR |
| 2024-05-07 | 4 | TransMedics Group, Inc. (TMDX) | Sale (S): 5,130 @ $124.76 · Sale (S): 6,895 @ $125.26 | EDGAR |
| 2024-05-03 | 4 | TransMedics Group, Inc. (TMDX) | Sale (S): 11,236 @ $105.70 · Sale (S): 1,704 @ $106.89 · Sale (S): 100 @ $108.47 · Sale (S): 2,000 @ $110 | EDGAR |
| 2024-03-05 | 4 | TransMedics Group, Inc. (TMDX) | Sale (S): 200 @ $81.41 · Sale (S): 4,234 @ $82.84 · Sale (S): 5,746 @ $83.63 · Sale (S): 2,900 @ $84.74 · Sale (S): 300 @ $85.48 | EDGAR |
| 2024-01-30 | 4 | GLOBUS MEDICAL INC (GMED) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2023-11-29 | 4 | TransMedics Group, Inc. (TMDX) | Sale (S): 10,000 @ $70.14 | EDGAR |
| 2023-07-05 | 4 | Lyra Therapeutics, Inc. (LYRA) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-05-30 | 4 | TransMedics Group, Inc. (TMDX) | Grant/award (A): 1,193 @ $0 · Grant/award (A): 1,916 (derivative) @ $0 | EDGAR |
| 2023-02-27 | 4 | TransMedics Group, Inc. (TMDX) | Sale (S): 10,000 @ $75.13 | EDGAR |
| 2023-02-27 | 4 | GLOBUS MEDICAL INC (GMED) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-08-01 | 4 | TransMedics Group, Inc. (TMDX) | Sale (S): 48,515 @ $39.98 | EDGAR |
| 2022-07-06 | 4 | TransMedics Group, Inc. (TMDX) | Sale (S): 48,515 @ $35 | EDGAR |
| 2022-06-06 | 4 | TransMedics Group, Inc. (TMDX) | Grant/award (A): 13,500 (derivative) @ $0 | EDGAR |
| 2022-05-06 | 4 | TransMedics Group, Inc. (TMDX) | Sale (S): 48,516 @ $29.94 | EDGAR |
| 2022-03-17 | 4 | GLOBUS MEDICAL INC (GMED) | Option exercise (M): 5,308 @ $43.58 · Option exercise (M): 3,542 @ $53.27 · Sale (S): 8,850 @ $65.47 · Option exercise (M): 5,308 (derivative) @ $0 · Option exercise (M): 3,542 (derivative) @ $0 | EDGAR |
| 2022-03-10 | 4 | GLOBUS MEDICAL INC (GMED) | Option exercise (M): 4,484 @ $43.58 · Sale (S): 4,484 @ $72 · Option exercise (M): 10,000 @ $43.58 · Sale (S): 10,000 @ $70.04 · Option exercise (M): 4,484 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2022-03-08 | 4 | Lyra Therapeutics, Inc. (LYRA) | Grant/award (A): 14,500 (derivative) @ $0 | EDGAR |
| 2022-01-31 | 4 | GLOBUS MEDICAL INC (GMED) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2021-12-16 | 4 | TransMedics Group, Inc. (TMDX) | Gift (G): 25,500 @ $0 | EDGAR |
| 2021-06-01 | 4 | TransMedics Group, Inc. (TMDX) | Grant/award (A): 13,500 (derivative) @ $0 | EDGAR |
| 2021-05-12 | 4 | GLOBUS MEDICAL INC (GMED) | Option exercise (M): 25,000 @ $43.77 · Sale (S): 25,000 @ $71.96 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2021-03-12 | 4 | Oxford Immunotec Global PLC (OXFD) | Disposition to issuer (D): 4,081 @ $22 · Disposition to issuer (D): 7,457 (derivative) @ $13.35 · Disposition to issuer (D): 7,457 (derivative) @ $7.54 · Disposition to issuer (D): 7,457 (derivative) @ $7.51 · Disposition to issuer (D): 7,457 (derivative) @ $7.56 · Disposition to issuer (D): 14,914 (derivative) @ $8.98 · +3 more | EDGAR |
| 2021-02-10 | 4 | TransMedics Group, Inc. (TMDX) | Sale (S): 9,968 @ $32.80 · Sale (S): 200 @ $34.18 | EDGAR |
| 2021-01-19 | 4 | GLOBUS MEDICAL INC (GMED) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2020-09-03 | 4 | GLOBUS MEDICAL INC (GMED) | Option exercise (M): 5,600 @ $26.27 · Sale (S): 5,600 @ $56.85 · Option exercise (M): 5,600 (derivative) @ $0 | EDGAR |
| 2020-08-26 | 4 | GLOBUS MEDICAL INC (GMED) | Option exercise (M): 17,400 @ $26.27 · Sale (S): 17,400 @ $54.40 · Option exercise (M): 17,400 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1190128 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs